What symptoms can posterior reversible encephalopathy syndrome cause in patients receiving daunorubicin hydrochloride as part of combination chemotherapy?

In patients receiving daunorubicin hydrochloride as part of combination chemotherapy, posterior reversible encephalopathy syndrome can cause headache, seizures, lethargy, confusion, blindness, and other visual and neurological disturbances, with mild to severe hypertension sometimes present.